Sclerosis, Progressive Systemic Completed Phase 2 Trials for Treprostinil (DB00374)

Also known as: Sclerosis, Systemic / Systemic Sclerosis / Progressive systemic sclerosis / Scleroderma, Systemic / Scleroderma

DBCOND0080156 (Sclerosis, Progressive Systemic)Completed2 IdentifierTitlePurposeDrugs
NCT00775463Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil DiethanolamineTreatment
NCT02663895Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic SclerosisTreatment